NEI Collaborative Clinical Vision Research (UG1 - Clinical Trial Optional)
National Institutes of Health · Department of Health and Human Services
At a glance
NEI Collaborative Clinical Vision Research (UG1 - Clinical Trial Optional) is a forecasted federal cooperative agreement opportunity from the National Institutes of Health (Department of Health and Human Services). The agency's forecast estimates an application due date of September 25, 2026; forecast dates can change. Applicant types listed as eligible include state governments, county governments, city or township governments, special district governments, independent school districts and 10 more. Cost sharing is not required. It is funded under Assistance Listing 93.867 (Vision Research).
Summary assembled from the official notice's fields. The official notice governs.
Key facts
- Mar 3, 2026Forecast posted
- Jul 25, 2026 (est.)Full notice expected
- Sep 25, 2026 (est.)Application deadline
- Jun 1, 2027 (est.)Est. award datenext date
- Posted
- Mar 3, 2026
- Est. close date
- Sep 25, 2026
- Est. award date
- Jun 1, 2027
- Award floor
- Not specified
- Award ceiling
- Not specified
- Est. total funding
- Not specified
- Expected awards
- Not specified
- Cost sharing
- Not required
- Funding instrument
- Cooperative Agreement
- Opportunity category
- Discretionary
- Fiscal year
- FY2027
Typical awards for this program (SAM.gov listing for ALN 93.867, not this notice): FOR 2023: Research Grants (R): $12,400 to $2,178,277; Avg $422,981. Cooperative Agreements: $10,980 to $7,324,750; Avg $1,067,398. Centers (P): $400,718 to $949,680; Avg $677,851. K (Institutional): $183,986 to $545,160; Avg $454,904. K (Individual): $15,332 to $277,133; Avg $177,182. NRSA (Institutional): $28,815 to $272,894; Avg $142,678. NRSA (Individual): $2,500 to $78,552; Avg $47,548. SBIR Phase I: $54,475 to $350,075; Avg $270,429. SBIR Phase II: $245,829 to $1,907,135; Avg $768,574. STTR Phase I: $149,664 to $341,302; Avg $273,829. STTR Phase II: $289,895 to $537,483; Avg $402,459. SBIR/STTR Phase III: none. FOR 2024 YTD: Research Grants (R): $4,455 to $2,153,230; Avg $428,107. Cooperative Agreements: $81,518 to $8,942,823; Avg $1,283,922. Centers (P): $161,000 to $947,710; Avg $654,204. K (Institutional): $285,890 to $562,320; Avg $478,162. K (Individual): $21,767 to $280,704; Avg $175,903. NRSA (Institutional): $29,506 to $555,162; Avg $144,608. NRSA (Individual): $3,000 to $81,892; Avg $51,319. SBIR Phase I: $54,709 to $365,000; Avg $259,725. SBIR Phase II: $52,865 to $1,093,927; Avg $821,791. STTR Phase I: $180,642 to $180,642; Avg $180,642. STTR Phase II: $615,858 to $975,387; Avg $767,351. SBIR/STTR Phase III: none YTD.
Who can apply
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public colleges & universities
- Federally recognized tribal governments
- Public & Indian housing authorities
- Native American tribal organizations
- 501(c)(3) nonprofits
- Nonprofits without 501(c)(3) status
- Private colleges & universities
- For-profit organizations (not small businesses)
- Small businesses
- Others (see notice)
Additional information on eligibility (from the notice)
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
A quick check against the listed applicant types — other requirements in the notice still apply.
Based on the published notice. Review the official notice for complete eligibility requirements.
What it funds
Official synopsis as published by the agency, formatted for readability.
The NEI uses UG1 cooperative agreement awards to support investigator-initiated clinical vision research projects, including multi-center clinical trials, human gene-transfer, stem cell therapy trials, epidemiological studies, and other studies that are complex, high resource, or that require increased oversight due to elevated safety considerations.
These collaborative clinical vision research projects would address chronic diseases across the lifespan through research on the burden of eye and vision conditions, their causes, diagnoses, prevention, treatment, and rehabilitation. These projects are multifaceted and of high public health significance, requiring careful oversight and monitoring by National Institutes of Health (NIH) staff.
The intent of this funding opportunity announcement is to provide a collaborative framework for the following components: Chair's Grant, Coordinating Center, and Resource Center(s).
How to apply
0 of 8 done · progress saved in this browser
Assistance Listing
What is an ALN?Reported obligations under ALN 93.867
Historical data · not a predictionAgency contact (as published)
NEI Extramural
NEI_extramural@nih.gov
Please contact via e-mail
Quick answers
Is “NEI Collaborative Clinical Vision Research (UG1 - Clinical Trial Optional)” open for applications yet?
Not yet. It is a forecast — an agency's advance notice of an expected opportunity. The agency estimates posting the full notice around July 25, 2026. Forecast details and dates can change.
Who is eligible to apply for “NEI Collaborative Clinical Vision Research (UG1 - Clinical Trial Optional)”?
The official notice lists these applicant types as eligible: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public colleges & universities, Federally recognized tribal governments, Public & Indian housing authorities, Native American tribal organizations, 501(c)(3) nonprofits, Nonprofits without 501(c)(3) status, Private colleges & universities and 3 more. Additional restrictions may apply; review the full notice.
How do I apply for “NEI Collaborative Clinical Vision Research (UG1 - Clinical Trial Optional)”?
Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity PAR-26-119), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.
Related open opportunities
Matched on shared Assistance Listings, agency, categories and eligible applicant types.
NEI New Innovator Award (DP2 Clinical Trial Not Allowed)
National Institutes of Health- Award range
- Amount not specified
- Est. close
- May 25, 2026 (est.)
- Who can apply
- Public colleges & universities, Private colleges & universities and Others (see notice)
NEI Center Core Grant for Vision Research (P30 Clinical Trial Not Allowed)
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Sep 25, 2026 (est.)
- Who can apply
- Public colleges & universities, 501(c)(3) nonprofits, Nonprofits without 501(c)(3) status and 2 more
Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
National Institutes of Health- Award range
- Amount not specified
- Closes
- Dec 3, 2026
- Who can apply
- Others (see notice)
Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed)
National Institutes of Health- Award range
- Amount not specified
- Closes
- Mar 5, 2027
- Who can apply
- State governments, County governments, City or township governments and 12 more
Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed)
National Institutes of Health- Award range
- Amount not specified
- Closes
- May 7, 2027
- Who can apply
- State governments, County governments, City or township governments and 12 more
NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)
National Institutes of Health- Award range
- Amount not specified
- Closes
- Oct 16, 2027
- Who can apply
- State governments, County governments, City or township governments and 12 more